Clinical trial
Tiotropium / Respimat One-Year Study
NCT00168831 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00168831 |
|---|---|
| Title | Tiotropium / Respimat One-Year Study |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Comparison of One-Year Treatment of Two Doses (5mg and 10mg) of Tiotropium Inhalation Solution Delivered by the Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug, Other |
| Interventions | Tiotropium Inhalation Solution, Placebo |
| Enrollment | 1,007 |
| Start date | Feb 1, 2003 |
| Primary completion | Jun 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 20, 2014 |
| Countries | Australia, Austria, Canada, Finland, France, Greece, Ireland, Italy, Netherlands, New Zealand, Russia, South Africa and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: